Life Science banker at SVB. Former economist & investor. Stats & science nerd. love brains. hate mayo. Views are my own; RTs not necessarily endorsements
Strong VC appetite points to healthy outlook
In our industry, Q1 is bookended by JP Morgan and the end of the tax year so it seems as tenuous a time as any to take stock of 2016.